BAKER DOUGLAS P 4
4 · OptimizeRx Corp · Filed Sep 9, 2021
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
BAKER DOUGLAS P
Chief Financial Officer
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-09-07$70.53/sh−2,232$157,423→ 48,564 total - Exercise/Conversion
Stock Option
2021-09-08$7.51/sh−10,000$75,100→ 44,699 totalExercise: $7.51From: 2020-06-30Exp: 2022-03-31→ Common Stock (10,000 underlying) - Sale
Common Stock (pursuant to 10B5-1 plan)
2021-09-08$67.25/sh−10,000$672,500→ 48,564 total - Exercise/Conversion
Common Stock
2021-09-08$7.51/sh+10,000$75,100→ 58,564 total
Footnotes (2)
- [F1]These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.